Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05845983 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

LA Improves the Prognosis of Patients With ICVD

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
3,531 trials monitored
See 153 trials at risk
Ischemic cerebrovascular disease will cause serious harm to the life and safety of patients, and the treatment prognosis is poor. Numerous clinical trials have demonstrated that probiotics can improve cognitive function in people under multimodal. We have previously found that Lactobacillus acidophilus administration could improve cognitive impairment in MCAO and BCAS mice. Therefore, Based on the above research background and the basis of previous studies, we believe that the administration of Lactobacillus acidophilus solid drink (pure Lactobacillus acidophilus strain) can improve the cognitive function of patients with cerebral ischemia through the "brain-gut axis".
Trial Details
NCT Number NCT05845983
Lead Sponsor Huaqiu Zhang
Conditions
(from sponsor)
Ischemia, Cerebrovascular Ischemia, Cognitive Impairment
Related terms Cerebral Infarction, Cognitive Dysfunction, Ischemia
Enrollment 236 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov